Dimensional Fund Advisors
DNTH icon

Dimensional Fund Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Dimensional Fund Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.4M Sell
242,955
-78,548
-24% -$8.15M ﹤0.01% 1986
2026
Q2 		$31.3M Sell
321,503
-3,937
-1% -$344K 0.01% 1832
2026
Q1 		$27.3M Buy
325,440
+114,767
+54% +$6.65M 0.01% 1824
2025
Q4 		$8.68M Buy
210,673
+201,984
+2,325% +$7.83M ﹤0.01% 2331
2025
Q3 		$342K Buy
+8,689
New +$222K ﹤0.01% 3051
2024
Q3 		– Sell
-19,726
Closed -$510K – 3362
2024
Q2 		$510K Sell
19,726
-2,002
-9% -$48.1K ﹤0.01% 3023
2024
Q1 		$652K Buy
21,728
+6,992
+47% +$152K ﹤0.01% 2998
2023
Q4 		$153K Buy
+14,736
New +$163K ﹤0.01% 3231
2022
Q3 		$216K Sell
9,562
-318
-3% -$8.71K ﹤0.01% 3220
2022
Q2 		$189K Sell
9,880
-878
-8% -$21.7K ﹤0.01% 3254
2022
Q1 		$500K Sell
10,758
-480
-4% -$26.2K ﹤0.01% 3153
2021
Q4 		$797K Sell
11,238
-740
-6% -$74.4K ﹤0.01% 3076
2021
Q3 		$1.4M Sell
11,978
-7,204
-38% -$839K ﹤0.01% 2954
2021
Q2 		$3M Buy
19,182
+7,317
+62% +$1.34M ﹤0.01% 2757
2021
Q1 		$2.25M Buy
11,865
+5,943
+100% +$1M ﹤0.01% 2824
2020
Q4 		$743K Buy
5,922
+1,181
+25% +$134K ﹤0.01% 3035
2020
Q3 		$516K Buy
4,741
+121
+3% +$14.3K ﹤0.01% 3056
2020
Q2 		$555K Buy
4,620
+2,609
+130% +$368K ﹤0.01% 3058
2020
Q1 		$202K Buy
+2,011
New +$373K ﹤0.01% 3208

Other funds holding DNTH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Dimensional Fund Advisors's DNTH Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Dianthus Therapeutics (DNTH) stake by 24% in Q3 2026, selling an estimated $8.15M and leaving 242,955 shares worth $21.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Dimensional Fund Advisors first reported a position in DNTH in Q1 2020 and has held it in 19 quarters since. The position peaked at $31.3M in Q2 2026. 77 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Dimensional Fund Advisors held 242,955 shares of Dianthus Therapeutics worth $21.4M as of Q3 2026.
  • Dimensional Fund Advisors sold 78,548 Dianthus Therapeutics shares in Q3 2026, an estimated $8.15M.
  • Dianthus Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1986 holding.
  • Dimensional Fund Advisors first reported a position in Dianthus Therapeutics in Q1 2020 and has held it in 19 quarters since.
  • Dimensional Fund Advisors's Dianthus Therapeutics position peaked at $31.3M in Q2 2026.
  • 77 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.